TAK
NYSEStockTakeda Pharmaceutical Company Limited
$17.75-0.03 (-0.14%)
52-Week Range
$13.23
$18.80
Key Stats
Market Cap
—
P/E Ratio
—
Dividend Yield
3.31%
Beta
0.10
Volume
2.1M
Avg Volume
2.5M
Performance
1M
-3.74%
3M
+21.63%
6M
+17.53%
YTD
+13.76%
1Y
+17.06%
3Y
+8.09%
5Y
-6.03%
Price Chart
ETF Exposure
TAK is held by 18 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| PPH | VanEck Pharmaceutical ETF | 2.93% |
| IDVO | Amplify CWP International Enhanced Dividend Income ETF | 1.54% |
| BAD | B.A.D. ETF | 1.51% |
| GERM | ETFMG Treatments, Testing and Advancements ETF | 0.89% |
| GINX | SGI Enhanced Global Income ETF | 0.86% |
| FVL | First Trust Value Line 100 Exchange-Traded Fund | 0.42% |
| FVD | First Trust Value Line Dividend Index Fund | 0.42% |
| AVSD | Avantis Responsible International Equity ETF | 0.07% |
| BDYN | iShares Dynamic Equity Active ETF | 0.06% |
| AVDE | Avantis International Equity ETF | 0.06% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.01% |
| VALT | ETFMG Sit Ultra Short ETF | 0.00% |
| VEU.AX | Vanguard All-World ex-U.S. Shares Index ETF | 0.00% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.00% |
| VEU | Vanguard FTSE All-World ex-US ETF | 0.00% |
| AFTY | Pacer CSOP FTSE China A50 ETF | 0.00% |
| DFAX | Dimensional - World ex US Core Equity 2 ETF | 0.00% |
| DFIC | Dimensional - International Core Equity 2 ETF | 0.00% |
About TAK ETF Exposure
Takeda Pharmaceutical Company Limited (TAK) is held by 18 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $17.75 with a dividend yield of 3.31%. Investors can gain exposure to TAK through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TAK, sorted by portfolio weight.